RNU6-86P

Across TCGA pan-cancer cohorts, RNU6-86P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-86P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-86P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-86P expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

OV, ACC, and STAD are the cancer types where RNU6-86P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.742	0.528	.007	60	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
STAD	OS	Tertile	IV	1.000	0.252	.008	36	view →
PAAD	DFS	Tertile	II,III,IV	0.247	0.461	.010	27	view →
KIRC	DFS	Tertile	All	0.712	0.810	.022	24	view →
KIRP	OS	Tertile	All	0.729	0.893	.004	24	view →
LIHC	DFS	Tertile	All	0.175	0.546	.009	18	view →
LUSC	OS	Tertile	All	0.381	0.727	.041	9	view →
PCPG	DFS	Tertile	All	0.167	0.819	.010	9	view →
BLCA	OS	Tertile	All	0.787	0.593	.034	6	view →
THYM	DFS	Tertile	II,III,IV	0.322	0.774	.014	6	view →
SARC	DFS	Tertile	All	0.384	0.645	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-86P–OV (DFS)

Open the OV breakdown →